Stock market today: Dalal Street opened in red on Tuesday, with benchmark indices slipping 0.9% as oil prices continued to rise and US President Donald Trump’s deadline for Iran nears. While Nifty50 began the day below 22,800, Sensex fell over 800 points in early trade to touch 73,282.41. As of 9:20 am, Nifty50 was trading at 22,765.45, down 202.80 or 0.88%. BSE Sensex made slight recovery, down 694.03 points or 0.94% to 73,412.82.This fall comes after a sharp rebound in the previous session, when both Sensex and Nifty recovered strongly, erasing early losses triggered by rising crude oil prices as tensions continued to intensify in the Middle East. Traders attributed the rise to intense buying in banking and IT stocks, along with a strengthening rupee, that lifted investor’s confidence.During the volatile session on Monday, the 30-share BSE Sensex surged 787.30 points, or 1.07%, to settle at 74,106.85. During intraday trade, it had jumped 887.91 points, or 1.21%, to touch 74,207.46. Market breadth remained firmly positive, with 3,207 stocks advancing, 1,147 declining and 190 remaining unchanged on the BSE.The 50-share NSE Nifty also ended higher, rising 255.15 points, or 1.12%, to close at 22,968.25. Rupee, however, stayed firm on Tuesday, opening at 93.0025 per US dollar, rising 0.06% from its previous close of 93.06 against the greenback.In global markets, oil prices climbed while equities showed a mixed trend as investors assessed Donald Trump’s latest deadline for Iran to reopen the strategic Strait of Hormuz or face being “decimated”.West Texas Intermediate rose 2.6% to $115.34 per barrel, and Brent North Sea crude gained 1.3% to $111.24 per barrel. Across Asia, Tokyo’s Nikkei 225 slipped 0.2% to 53,323.41 in early trade, while Shanghai’s Composite index rose 0.5% to 3,899.09. Hong Kong’s Hang Seng Index remained closed for a holiday.In currency markets, euro weakened to $1.1530 from $1.1543 on Monday, while the pound dipped to $1.3216 from $1.3236. The dollar strengthened against the yen to 159.86 from 159.68. The euro also edged lower against the pound to 87.25 pence from 87.27 pence. In the US, the Dow Jones Industrial Average ended 0.4% higher at 46,669.88, while London markets were closed for a holiday.

Applied Nutrition is significantly expanding its product range to cater to customers using weight loss drugs, following a substantial increase in demand over the past year.

The health and wellness brand said it has identified a key business opportunity stemming from the sharp rise in Britons using GLP-1 treatments, such as Mounjaro and Wegovy.

The London-listed company, which already offers GLP-1-friendly high-protein ready meals launched in late 2025, confirmed that new products specifically designed for this market will be introduced later this year.

“The GLP-1 user is a growing customer. We see this as a consumer at the start of their weight loss journey who is now looking at how the medication can help them,” Thomas Ryder, founder and chief executive of the Liverpool-based firm, said.

“There is an opportunity, as those customers often need supplements and need smaller portions. I think this is a catalyst for the health and wellness space if we have that consumer in mind.

“We do have a number of products we will bring to market in this area because we do see that area growing.”

At least 1.6 million Britons have used weight loss jabs in the past year, according to research by University College London.

Applied Nutrition has reported strong growth, driven by targeting new customer opportunities and diversifying its sales channels, including expansion into UK retail stores.

In March, the company announced robust financial results, with pre-tax profits soaring by 77.1% to £20.9 million for the six months ending 31 January, compared to the previous year.

Sales also saw a significant uplift, rising by 56.5 per cent to £74.5 million over the same half-year period.

However, the firm cautioned that sales volumes in the Middle East are expected to be affected by the ongoing conflict in the region.

Applied Nutrition said it still expects to meet revenue targets for the year of around £140 million.

The company added: “Importantly, we have managed similar disruption in the past, supported by the agility of our operations.

“In this instance, we are working closely with customers to adapt our routes into the region and logistics arrangements to safeguard continued supply to those customers.”